This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
This fact sheet discusses the deadly duo of TB-HIV, and how members of both TB and HIV communities can work together.
These brief, interactive self-study case studies allow you to practice locating areas of radiographic abnormalities using real-life clinical scenarios.
This website is an open-access resource library of radiographic images of tuberculosis. Individuals may use these images to gain an appreciation for the broad spectrum of radiographic manifestations of tuberculosis. The images are free to download and share for non-commercial educational purposes...
This series of interactive modules was developed by the Association of Public Health Laboratories (APHL) in collaboration with the Centers for Disease Control and Prevention. Topics include laboratory safety, specimen collection, AFB smear microscopy, mycobacterial culture, and drug susceptibility...
These four webinars highlight challenges, legal requirements, and best practice strategies for preventing and controlling TB in correctional facilities. These webinars were produced by the Minnesota Department of Health in consultation with several local public health agencies and correctional...
The purpose of this training toolkit is to build the capacity of health care workers to address and manage TB in children. The toolkit consists of ten modules. Topics include epidemiology of childhood TB, diagnosis, treatment, prevention, TB/HIV co-infection, multidrug-resistant TB, and community...
This booklet discusses TB in correctional facilities.
This document presents lessons learned in regards to strengthening TB care, implementing new approaches TB case detection, and increasing TB case notifications.
This handbook provides detailed examples of the analysis of TB surveillance data, in particular TB notification data, data from surveillance of anti-TB drug resistance, and mortality data compiled in national vital registration systems.
